A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This study will attempt to study the effect of memantine, on memory, and motor
praxis/expressive language skills in children with autism.
The investigators will recruit children ages 6-12 years who are verbal and meet criteria for
Autism Spectrum Disorder. The children will be assessed for memory function, expressive
language output and motor skills/praxis. They will then be randomized to memantine or placebo
for 6 months. The effects of this medication and its safety in this population will be
studied over the 6 month period.
Phase:
Phase 2
Details
Lead Sponsor:
Evdokia Anagnostou
Collaborators:
Icahn School of Medicine at Mount Sinai Nationwide Children's Hospital Rush University Medical Center